Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucosamine/Chondroitin Sulfate (Eurofarma) vs Cosamin DS in Knee Osteoarthritis
NCT00955552Phase 3Completed
- Sponsor
- Eurofarma
- Start
- Aug 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Cosamin DS with Glucosamine/chondroitin sulphate (2 arms). Primary endpoints: Efficacy of the Association at 5 months and Safety of the Association at 5 months. Started Aug 2010; status: completed.
02
Drugs
glucosamine sulphatechondroitin sulfate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00955552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00955552.